9999999997-20-003782.txt : 20200626 9999999997-20-003782.hdr.sgml : 20200626 20200626111251 ACCESSION NUMBER: 9999999997-20-003782 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200626 DATE AS OF CHANGE: 20200626 ACTION DATE: 20200626 RECEIVED DATE: 20200626 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 20992047 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-466-3500 MAIL ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 CT ORDER 1 filename1.pdf begin 644 filename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